Fulvestrant
Breast, Malignant Neoplasms, PI3K Gene Mutation + 4 more
Treatment
8 FDA approvals
1 Active Study for Fulvestrant
Treatment for
Breast
What is Fulvestrant
Fulvestrant
The Generic name of this drug
Treatment Summary
Fulvestrant is a type of hormone therapy used to treat breast cancer in post-menopausal women whose cancer has progressed despite taking anti-estrogen medications. It works by blocking and destroying the estrogen receptor, which helps slow the growth of the cancer. It is most often used as a single drug treatment but may also be combined with alpelisib for certain types of breast cancer.
Faslodex
is the brand name
Fulvestrant Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Faslodex
Fulvestrant
2010
29
Approved as Treatment by the FDA
Fulvestrant, commonly known as Faslodex, is approved by the FDA for 8 uses which include Progression, Disease and Advanced or Metastatic Breast Cancer .
Progression, Disease
Used to treat Progression, Disease in combination with Abemaciclib
Advanced or Metastatic Breast Cancer
Used to treat Advanced or Metastatic Breast Cancer in combination with Abemaciclib
PI3K Gene Mutation
Used to treat PI3K Gene Mutation in combination with Alpelisib
Disease
Used to treat disease progression after endocrine based therapy in combination with Alpelisib
PIK3CA Gene Mutation
Used to treat PIK3CA Gene Mutation in combination with Alpelisib
Malignant Neoplasms
Used to treat Advanced or Metastatic Breast Cancer in combination with Abemaciclib
Disease Progression
Used to treat Progression, Disease in combination with Abemaciclib
prior endocrine therapy
Used to treat prior endocrine therapy in combination with Abemaciclib
Effectiveness
How Fulvestrant Affects Patients
Fulvestrant is a type of medicine given by injection that blocks the action of the hormone estrogen. It does not have any known effects that imitate estrogen.
How Fulvestrant works in the body
Fulvestrant is used to treat estrogen-sensitive breast cancer. It works by blocking the estrogen receptors in cancer cells. This prevents estrogen from binding to these receptors, and also causes them to break down. This helps stop the growth of cancers that are resistant to tamoxifen, as well as those that are sensitive to estrogen.
When to interrupt dosage
The proposed dosage of Fulvestrant is contingent upon the identified condition, including Progression, Disease, Breast and PIK3CA Gene Mutation. The volume of dosage is contingent upon the mode of delivery (e.g. Solution or Injection), which has been defined in the table below.
Condition
Dosage
Administration
Breast
, 250.0 mg/mL, 50.0 mg/mL, 250.0 mg
Solution - Intramuscular, Solution, , Intramuscular, Injection, solution, Injection, solution - Intramuscular, Injection - Intramuscular, Injection
PIK3CA Gene Mutation
, 250.0 mg/mL, 50.0 mg/mL, 250.0 mg
Solution - Intramuscular, Solution, , Intramuscular, Injection, solution, Injection, solution - Intramuscular, Injection - Intramuscular, Injection
Malignant Neoplasms
, 250.0 mg/mL, 50.0 mg/mL, 250.0 mg
Solution - Intramuscular, Solution, , Intramuscular, Injection, solution, Injection, solution - Intramuscular, Injection - Intramuscular, Injection
PI3K Gene Mutation
, 250.0 mg/mL, 50.0 mg/mL, 250.0 mg
Solution - Intramuscular, Solution, , Intramuscular, Injection, solution, Injection, solution - Intramuscular, Injection - Intramuscular, Injection
Disease Progression
, 250.0 mg/mL, 50.0 mg/mL, 250.0 mg
Solution - Intramuscular, Solution, , Intramuscular, Injection, solution, Injection, solution - Intramuscular, Injection - Intramuscular, Injection
Disease
, 250.0 mg/mL, 50.0 mg/mL, 250.0 mg
Solution - Intramuscular, Solution, , Intramuscular, Injection, solution, Injection, solution - Intramuscular, Injection - Intramuscular, Injection
prior endocrine therapy
, 250.0 mg/mL, 50.0 mg/mL, 250.0 mg
Solution - Intramuscular, Solution, , Intramuscular, Injection, solution, Injection, solution - Intramuscular, Injection - Intramuscular, Injection
Warnings
There are 2 known major drug interactions with Fulvestrant.
Common Fulvestrant Drug Interactions
Drug Name
Risk Level
Description
Ospemifene
Major
The risk or severity of adverse effects can be increased when Fulvestrant is combined with Ospemifene.
Fluoroestradiol F-18
Moderate
Fulvestrant may decrease effectiveness of Fluoroestradiol F-18 as a diagnostic agent.
Fulvestrant Toxicity & Overdose Risk
There is no known experience of overdosing on this drug in humans.
Fulvestrant Novel Uses: Which Conditions Have a Clinical Trial Featuring Fulvestrant?
At present, 20 clinical trials are assessing the potential of Fulvestrant to inhibit Progression of Disease, Breast Cancer and Malignant Neoplasms.
Condition
Clinical Trials
Trial Phases
Breast
0 Actively Recruiting
Malignant Neoplasms
0 Actively Recruiting
Disease
0 Actively Recruiting
PIK3CA Gene Mutation
0 Actively Recruiting
Disease Progression
0 Actively Recruiting
PI3K Gene Mutation
1 Actively Recruiting
Phase 1
prior endocrine therapy
0 Actively Recruiting
Fulvestrant Reviews: What are patients saying about Fulvestrant?
4
Patient Review
10/25/2013
Fulvestrant for Metastatic Breast Cancer Progression Post-Antiestrogen Therapy
4
Patient Review
10/30/2017
Fulvestrant for Metastatic Breast Cancer Progression Post-Antiestrogen Therapy
3.7
Patient Review
6/5/2013
Fulvestrant for Metastatic Breast Cancer Progression Post-Antiestrogen Therapy
1.7
Patient Review
9/25/2009
Fulvestrant for Metastatic Breast Cancer Progression Post-Antiestrogen Therapy
Patient Q&A Section about fulvestrant
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How long can you take fulvestrant?
"Fulvestrant is most commonly given to patients in hospitals every two weeks for the first three doses, and then once a month. Fulvestrant is often given to patients for as long as it is successful in controlling their breast cancer and any side effects can be managed."
Answered by AI
Is fulvestrant a chemotherapy?
"Faslodex is a hormonal therapy that blocks estrogen receptors in the body, which may help to treat breast cancer. Faslodex can be used alone or in combination with other medications."
Answered by AI
What are the side effects of fulvestrant?
"If you experience any of the following symptoms, you should see a doctor as soon as possible: black or tarry stools, bloating or swelling of the face, arms, hands, lower legs, or feet, blood in the urine or stools, chest pain or tightness, cloudy urine, difficulty breathing, hoarseness, or irregular heartbeat."
Answered by AI